Perceived benefits and constraints in vehicle automation: Data to assess the relationship between driver's features and their attitudes towards autonomous vehicles

por Lijarcio, Ignacio, Useche, Sergio A., Llamazares, Javier, Montoro, Luis
Publicado 2019

Are Your Eyes “on the Road”? Findings from the 2019 National Study on Vision and Driving Safety in Spain

por Lijarcio, Ignacio, Useche, Sergio A., Llamazares, Javier, Montoro, Luis
Publicado 2020

More Than Just “Stressful”? Testing the Mediating Role of Fatigue on the Relationship Between Job Stress and Occupational Crashes of Long-Haul Truck Drivers

por Useche, Sergio A, Alonso, Francisco, Cendales, Boris, Llamazares, Javier
Publicado 2021

Measuring job stress in transportation workers: psychometric properties, convergent validity and reliability of the ERI and JCQ among professional drivers

por Useche, Sergio A., Alonso, Francisco, Cendales, Boris, Montoro, Luis, Llamazares, Javier
Publicado 2021

Essential…but also vulnerable? Work intensification, effort/reward imbalance, fatigue and psychological health of Spanish cargo drivers during the COVID-19 pandemic

por Montoro, Luis, Cendales, Boris, Alonso, Francisco, Gonzalez-Marin, Adela, Lijarcio, Ignacio, Llamazares, Javier, Useche, Sergio A.
Publicado 2022

PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in Psoriasis

por Stein Gold, Linda, Alonso-Llamazares, Javier, Lacour, Jean-Philippe, Warren, Richard B., Tyring, Stephen K., Kircik, Leon, Yamauchi, Paul, Lebwohl, Mark
Publicado 2020

Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial

por Stein Gold, Linda, Alonso-Llamazares, Javier, Draelos, Zoe D., Gooderham, Melinda J., Kempers, Steven E., Kircik, Leon H., Lebwohl, Mark G., Papp, Kim A., Pariser, David M., Toth, Darryl P., Yosipovitch, Gil, Higham, Robert C., Feng, Amy, Berk, David R.
Publicado 2022

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial

por Zirwas, Matthew J., Draelos, Zoe D., DuBois, Janet, Kircik, Leon H., Moore, Angela Y., Stein Gold, Linda, Alonso-Llamazares, Javier, Bukhalo, Michael, Bruce, Suzanne, Eads, Kimmie, Green, Lawrence J., Guenthner, Scott T., Ferris, Laura K., Forman, Seth B., Kempers, Steven E., Lain, Edward, Lynde, Charles W., Pariser, David M., Toth, Darryl P., Yamauchi, Paul S., Higham, Robert C., Krupa, David, Burnett, Patrick, Berk, David R.
Publicado 2023